Switch to:
PDL BioPharma Inc  (NAS:PDLI) EV-to-EBIT: 2.09 (As of Today)

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PDL BioPharma Inc's Enterprise Value is $337.2 Mil. PDL BioPharma Inc's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 was $161.0 Mil. Therefore, PDL BioPharma Inc's EV-to-EBIT for today is 2.09.

NAS:PDLI' s EV-to-EBIT Range Over the Past 10 Years
Min: 0.8   Max: 13.3
Current: 2.09

0.8
13.3

During the past 13 years, the highest EV-to-EBIT of PDL BioPharma Inc was 13.30. The lowest was 0.80. And the median was 3.60.

NAS:PDLI's EV-to-EBIT is ranked higher than
89% of the 253 Companies
in the Global industry.

( Industry Median: 23.72 vs. NAS:PDLI: 2.09 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PDL BioPharma Inc's Enterprise Value for the quarter that ended in Jun. 2017 was $183.1 Mil. PDL BioPharma Inc's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 was $161.0 Mil. PDL BioPharma Inc's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2017 was 87.95%.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

PDL BioPharma Inc Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.22 3.46 2.61 1.10 2.71

PDL BioPharma Inc Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 1.98 2.71 3.81 1.14

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calculation

PDL BioPharma Inc's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=337.173/161.024
=2.09

PDL BioPharma Inc's current Enterprise Value is $337.2 Mil.
PDL BioPharma Inc's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 was 32.817 (Sep. 2016 ) + -9.837 (Dec. 2016 ) + 18.717 (Mar. 2017 ) + 119.327 (Jun. 2017 ) = $161.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PDL BioPharma Inc's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2017 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2017 =EBIT / Enterprise Value (Q: Jun. 2017 )
=161.024/183.0916
=87.95 %

PDL BioPharma Inc's Enterprise Value for the quarter that ended in >Jun. 2017 was $183.1 Mil.
PDL BioPharma Inc's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 was 32.817 (Sep. 2016 ) + -9.837 (Dec. 2016 ) + 18.717 (Mar. 2017 ) + 119.327 (Jun. 2017 ) = $161.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms


Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK